Nanosonics | NAN - 销售收入



金融业
股票价格
AUD 2.86
资产
AUD 279.25M
现金及等价物
AUD 161.29M
销售成本
AUD 24.23M
流动资产
AUD 234.13M
流动负债
AUD 36.59M
债务
AUD 7.69M
EBIT
AUD 9.12M
EBITDA
AUD 12.49M
员工
470
EPS每股收益
AUD 0.03
股本和储备
AUD 219.69M
销售毛利
AUD 78.01M
债务利息支出
AUD 779K
利息收入
AUD 2.89M
贷款资金
AUD 3.21M
市值
AUD 866.29M
净收入
AUD 9.64M
营业费用
AUD 93.11M
营业利润
AUD 9.12M
普通股股本
AUD 303.35M
PE价格收益
65.33
税前利润
AUD 11.39M
销售收入
AUD 102.23M
销售和管理费用
AUD 53.78M
股票
AUD 18.63M
贸易债权人
AUD 12.22M
应收帐款人
AUD 46.45M


销售 更改 日
Alcidion AUD 25.47M 2.32M 2025-12
Ansell USD 1.03B 192.2M 2025-12
Avita Medical AUD 17.61M 805K 2025-12
Cochlear AUD 1.18B 590.35M 2025-12
CSL USD 8.33B 4.79B 2025-12
Fisher & Paykel Healthcare NZD 1.24B 149.9M 2026-06
Healius AUD 688.1M 245.8M 2025-12
Integral Diagnostics AUD 238.44M 7.19M 2024-06
Mayne Pharma AUD 86.5M 125.57M 2026-06
Polynovo AUD 79.52M 9.19M 2026-06
Pro Medicus AUD 141.81M 12.87M 2026-06
Ramsay Health Care AUD 9.24B 100M 2026-12
ResMed USD 1.43B 8.6M 2026-03
Somnomed AUD 45.11M 1.46M 2023-12
Sonic Healthcare AUD 5.42B 30M 2026-06